RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2

Keyphrases

• Breast Tumor 100%
• Tumor Metastasis 100%
• Lysyl Oxidase 100%
• Syndecan-2 100%
• Tumor Survival 100%
• High-mobility Group AT-hook 2 (HMGA2) 100%
• MiR-200 60%
• Signaling Pathway 40%
• Metastasis 40%
• Metastasis Suppressor 40%
• Breast Cancer 20%
• Breast Cancer Patients 20%
• Extracellular Matrix 20%
• Statistical Analysis 20%
• Tumor Growth 20%
• Human Breast Tumor 20%
• Downstream Targets 20%
• Oncogene 20%
• Experimental Validation 20%
• Apoptosis Induction 20%
• Metastasis-free Survival 20%
• Breast Cancer Model 20%
• Breast Tumor Cells 20%
• Mouse Xenograft 20%
• ER+ Breast Cancer 20%
• Raf Kinase Inhibitor Protein 20%
• Prognostic Signature 20%
• Architectural Transcription Factor 20%
• Tumor Metastasis Suppressor 20%
• PEBP1 20%
• Tumor Gene Expression Data 20%
• Key Signaling Pathways 20%

Biochemistry, Genetics and Molecular Biology

• High-Mobility Group 100%
• Syndecan 100%
• Lysyl Oxidase 100%
• Signal Transduction 60%
• Metastasis Suppressor 60%
• Transcription Factors 20%
• Downregulation 20%
• Tumor Progression 20%
• Gene Expression Data 20%
• Oncogene 20%
• Mouse Mammary Tumor Virus 20%
• Tumor Gene 20%
• Metastasis Free Survival 20%
• Raf Kinase 20%
• Mir-200 20%
• Programmed Cell Death 20%